Using a murine model of metastatic breast cancer, we present the first in vivo visualization of systemic tumor-mediated effects on immune cells and establish S100A8/A9 as a surrogate marker for immunomodulation in the context of pre-metastatic lung tissue priming. This evidence concerns the gene S100A8 and breast carcinoma.